Pixium Vision SA Company

Pixium Vision develops retinal implant systems for patients who have lost their eyesight.

Total Funding: 40955870.0
Headquarters: Paris, Ile-de-France, France
Funding Status: IPO
Estimated Revenue: $1M to $10M
Last Funding Type: Post-IPO Equity
Last Funding Date: 2020-07-15
Investors Number: 7.0
Founded Date: 2011-01-01
Industry: Neurodegenerative disease diagnosis and treatment